Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...

Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings ...

With a market cap of $799.5 billion, Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a leading global ...

Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in this morning's Q4 earnings report. Heading into the report, analysts ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes drug ...

Investing.com - Eli Lilly's (NYSE: LLY) full-year profit forecast largely surpassed Wall Street expectations on Thursday, as ...

Meanwhile, its Zepbound weight-loss drug grew by 52% against the previous quarter to $1.91 billion, also below expectations. Eli Lilly’s stock rose on the news, and at 10.59AM ET it was up 3.2%.

Most analysts are forecasting only $22.69 per-share profit this year. With Lilly stock priced at about 37 times current year earnings, and still doubling those earnings every year, there's a ...

Eli Lilly (LLY) investors should expect fireworks ... to reduced demand and cautious stocking by pharmacies, triggering stock price volatility amid lower revenue projections.

Eli Lilly (LLY) stock is higher Thursday after ... According to S&P Global Market Intelligence, the consensus analyst target price for LLY stock is $975.09, representing implied upside of about ...